Rotzinger David C, Knebel Jean-François, Jouannic Anne-Marie, Adler Ghazal, Qanadli Salah D
Cardiothoracic and Vascular Division, Department of Diagnostic and Interventional Radiology (D.C.R., A.M.J., S.D.Q.) and EEG Brain Mapping Core, Centre for Biomedical Imaging (CIBM) and Laboratory for Investigative Neurophysiology (The LINE), Department of Radiology (J.F.K.), Lausanne University Hospital (CHUV), Rue du Bugnon 46, 1011 Lausanne, Switzerland; Faculty of Biology and Medicine (FBM), University of Lausanne (UNIL), Lausanne, Switzerland (D.C.R., J.F.K., S.D.Q.); and Imagerive Diagnostic Radiology Institute, Geneva, Switzerland (G.A.).
Radiol Cardiothorac Imaging. 2020 Aug 27;2(4):e190188. doi: 10.1148/ryct.2020190188. eCollection 2020 Aug.
To investigate the prognostic value of an integrative approach combining clinical variables and the Qanadli CT obstruction index (CTOI) in patients with nonmassive acute pulmonary embolism (PE).
This retrospective study included 705 consecutive patients (mean age, 63 years; range, 18-95 years) with proven PE. Clot burden was quantified using the CTOI, which reflects the ratio of fully or partially obstructed pulmonary arteries to normal arteries. Patients were subdivided into two groups according to the presence (group A) or absence (group B) of preexisting cardiopulmonary disease. Thirty-day and 3-month mortality was evaluated. CTOI thresholds of 20% and 40% were used to stratify patients regarding outcome (low, intermediate, and high risk). The predictive value of CTOI was assessed through logistic regression analysis.
Analysis included 690 patients (mean age, 63.3 years ± 18 [standard deviation]) with complete follow-up data: 247 (36%) in group A and 443 (64%) in group B. The mean CTOI was 23% ± 19, 30-day mortality was 9.7%, and 3-month mortality was 11.6%. Three-month mortality was higher in group A than in group B (17.8% and 8.1%, respectively; = .001). Within group B, CTOI predicted outcome and allowed stratification: significantly higher mortality with CTOI greater than 40% ( < .001) and lower mortality with CTOI less than 20% ( = .05). CTOI did not predict outcome in group A. Age was an independent mortality risk factor ( ≤ .04).
CTOI predicted outcome in this cohort of patients with PE and no cardiopulmonary disease, and it may provide a simple single-examination-based approach for risk stratification in this subset of patients.© RSNA, 2020See also the commentary by Kay and Abbara in this issue.
探讨综合临床变量和卡纳德利CT阻塞指数(CTOI)对非大面积急性肺栓塞(PE)患者的预后价值。
这项回顾性研究纳入了705例连续确诊为PE的患者(平均年龄63岁;范围18 - 95岁)。使用CTOI对血栓负荷进行量化,CTOI反映完全或部分阻塞的肺动脉与正常动脉的比例。根据是否存在基础心肺疾病将患者分为两组(A组)或不存在基础心肺疾病(B组)。评估30天和3个月死亡率。使用20%和40%的CTOI阈值对患者进行结局分层(低、中、高风险)。通过逻辑回归分析评估CTOI的预测价值。
分析纳入了690例患者(平均年龄63.3岁±18[标准差]),这些患者有完整的随访数据:A组247例(36%),B组443例(64%)。平均CTOI为23%±19,30天死亡率为9.7%,3个月死亡率为11.6%。A组3个月死亡率高于B组(分别为17.8%和8.1%;P = 0.001)。在B组中,CTOI可预测结局并进行分层:CTOI大于40%时死亡率显著更高(P < 0.001),CTOI小于20%时死亡率更低(P = 0.05)。CTOI在A组中不能预测结局。年龄是独立的死亡风险因素(P≤0.04)。
CTOI可预测该组无心肺疾病的PE患者的结局,并且它可能为该亚组患者的风险分层提供一种基于单一检查的简单方法。©RSNA,2020另见本期Kay和Abbara的评论。